1 – 10 of 32
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Plasma p-tau217, NfL, GFAP diagnostic performance and biomarker profiles in Alzheimer's disease, frontotemporal dementia, and psychiatric disorders, in a prospective unselected neuropsychiatry memory clinic
- Contribution to journal › Article
-
Mark
Combining plasma p-tau217 and cross-cultural cognitive tests to identify Alzheimer's Disease in an ethnically diverse mixed memory clinic cohort
- Contribution to journal › Article
-
Mark
Reversible tau hyperphosphorylation in hibernation : a blood biomarker and brain tissue study
- Contribution to journal › Article
-
Mark
Evidence-based standardized sample handling protocol for accurate blood-based Alzheimer's disease biomarker measurement : Results and consensus of the Global Biomarker Standardization Consortium
- Contribution to journal › Article
-
Mark
Association of plasma Alzheimer's disease biomarkers with cognitive decline in cognitively unimpaired individuals
- Contribution to journal › Article
-
Mark
Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias : An international multi-center study
- Contribution to journal › Article
-
Mark
Influence of ethnicity on the diagnostic accuracy of plasma p-tau217 for the identification of Alzheimer's disease : A consecutive mixed memory clinic cohort study
- Contribution to journal › Article
-
Mark
A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests
- Contribution to journal › Article
-
Mark
Prediction of continuous amyloid positron emission tomography with fluid measures of phosphorylated tau and β-amyloid
(2025) In EMBO Molecular Medicine
- Contribution to journal › Article
-
Mark
Plasma and MRI biomarkers capture neuronal damage in former professional boxers
- Contribution to journal › Article
